BOMBAY BURMAH TRADING CORPORATION
Back to Balance Sheet
|
BOMBAY BURMAH TRADING CORPORATION Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹439 Cr | ₹396 Cr | ₹389 Cr | ₹412 Cr | ₹145 Cr |
What is the latest Contingent Liabilities ratio of BOMBAY BURMAH TRADING CORPORATION ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹439 Cr |
Mar2023 | ₹396 Cr |
Mar2022 | ₹389 Cr |
Mar2021 | ₹412 Cr |
Mar2020 | ₹145 Cr |
How is Contingent Liabilities of BOMBAY BURMAH TRADING CORPORATION Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹439 Cr | 10.96 | |
Mar2023 | ₹396 Cr | 1.73 | |
Mar2022 | ₹389 Cr | -5.65 | |
Mar2021 | ₹412 Cr | 184.57 | |
Mar2020 | ₹145 Cr | - |
Compare Contingent Liabilities of peers of BOMBAY BURMAH TRADING CORPORATION
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BOMBAY BURMAH TRADING CORPORATION | ₹12,338.2 Cr | 0% | 4.6% | 14.7% | Stock Analytics | |
KAVERI SEED COMPANY | ₹7,489.8 Cr | 15.2% | 43.4% | 108.6% | Stock Analytics | |
VENKYS (INDIA) | ₹2,300.1 Cr | 1.1% | -0.1% | 1.6% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,298.6 Cr | 2.4% | -4.8% | -49.4% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE | ₹452.8 Cr | -9.3% | -12.6% | NA | Stock Analytics | |
INDO US BIOTECH | ₹322.8 Cr | -1% | -18.2% | -39.7% | Stock Analytics |
BOMBAY BURMAH TRADING CORPORATION Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BOMBAY BURMAH TRADING CORPORATION | 0% |
4.6% |
14.7% |
SENSEX | -2.9% |
3.1% |
1.8% |
You may also like the below Video Courses